On the other hand, concomitantly with the reduced expression of PD-L1, we observed in both ObR sh xenografts, a decreased immunoreactivity of PD-1, highlighting the involvement of ObR in modulating tumor immune responses. This evidence concerns the gene PDCD1 and neoplasm.